Study Of Dalbavancin Drug Levels Achieved In Hospitalized Adolescents Who Are Receiving Antibiotic Therapy For Bacterial Infections

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions

Bacterial Infections

Interventions

DRUG

Dalbavancin

Subjects weighing \> 60 Kg: 1 gram IV single dose Subjects weighing \< 60 Kg: 15 mg/Kg IV

Trial Locations (3)

Pfizer Investigational Site, Louisville

Pfizer Investigational Site, Cleveland

Pfizer Investigational Site, San Diego